Hepatitis C Virus Protease Inhibitors has 2 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Brincidofovir. Patients taking Hepatitis C Virus Protease Inhibitors should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Moderate
- 1
Moderate (1)
- Hepatitis C Virus Protease Inhibitors + Brincidofovir— OATP1B1/1B3 inhibitors increase brincidofovir AUC and Cmax, may increase adverse reactions. Monitor for elevations in tr…